Format

Send to

Choose Destination
Infect Drug Resist. 2019 Apr 2;12:759-762. doi: 10.2147/IDR.S184598. eCollection 2019.

Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents.

Author information

1
Department of Tropical Medicine and Gastroenterology, Qena Faculty of Medicine, South Valley University, Qena, Egypt, Mohamad.mounir1981@gmail.com.

Abstract

Background:

We performed a case-series analysis of reactivation of herpesvirus in patients with hepatitis C virus (HCV) infection treated with direct-acting antiviral (DAA) agents.

Methods:

Eight cases were detected among 100 treated patients with DAA regimens in Qena University Hospital from June 2016 to June 2017. Herpesvirus was reactivated in eight patients who received DAA therapy. None of the cases had risk factor for herpes zoster reactivation.

Results:

The DAA regimens used were sofosbuvir/daclatasvir in six cases and sofosbuvir/ledipasvir in two cases. Immune changes that follow HCV clearance might lead to reactivation of other viruses, such as herpesvirus.

Conclusion:

Patients with HCV infection suspected of having herpesvirus infection should be treated promptly.

KEYWORDS:

DAA; HCV; HZ

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center